ThyroChek // Corporate
ThyroChek® tests are manufactured by Screening Devices Canada, Inc., a Canadian corporation located in Hatfield Point, New Brunswick.
Shareholders in the company are 20 Maritime business people who are part of the First Angel Network Association of Halifax, the Southwest Community Business Development Corporation, Harvey and a US investment group with a distinct interest in thyroid health. Additional financing has come from CBDC Charlotte/Kings as well as Enterprise Saint John.
SD Canada is a product development, marketing and sales company focused on point of care tests for front line health care. Bringing ThyroChek to the US market has been its first activity. It is FDA regulated and CE marked. Several more thyroid health related products are planned for a market that is described as $1.2 billion US.
Recent Press: Screening Devices Canada to create first of its kind test - Read the full story (Telegraph Journal)
11/09/NBIF Conference, Fredericton, NB
Publications PDF Articles on Hypothyroidism
Product Inserts
Sell Sheets
“Based on the less-than-1% discordance rate between sTSH and FT4 results, an sTSH level alone is adequate to screen outpatients for thyroid dysfunction. Ordering the sTSH alone,initially, followed by FT4 in only those cases of abnormal sTSH, will significantly decrease unnecessary testing and expense.”
Dr. Anthony J. Viera
American Academy of Family Physicians. Award winner for his study while a resident at the Family Practice Unit at the Jacksonville Naval Hospital, 2002
ThyroChek
© 2008 ThyroChek. All Rights Reserved.
Stay Connected
Keep track of ThyroChek Online.
Contact Information
Tel: 647 477 5672
Fax: 506 485 5932
www.thyrochek.com